KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $50.1 million.

  • Twist Bioscience's Receivables - Net rose 2733.56% to $50.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.1 million, marking a year-over-year increase of 2733.56%. This contributed to the annual value of $57.0 million for FY2025, which is 6336.42% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Receivables - Net is $50.1 million, which was up 2733.56% from $57.0 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Receivables - Net peaked at $57.0 million during Q3 2025, and registered a low of $27.3 million during Q1 2021.
  • Over the past 5 years, Twist Bioscience's median Receivables - Net value was $40.3 million (recorded in 2022), while the average stood at $40.4 million.
  • Per our database at Business Quant, Twist Bioscience's Receivables - Net skyrocketed by 11065.41% in 2021 and then plummeted by 2530.56% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Receivables - Net stood at $32.9 million in 2021, then soared by 35.18% to $44.4 million in 2022, then decreased by 20.44% to $35.4 million in 2023, then increased by 11.2% to $39.3 million in 2024, then grew by 27.34% to $50.1 million in 2025.
  • Its last three reported values are $50.1 million in Q4 2025, $57.0 million for Q3 2025, and $49.9 million during Q2 2025.